207 related articles for article (PubMed ID: 33604316)
1. A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.
Diesinger T; Lautwein A; Bergler S; Buckert D; Renz C; Dvorsky R; Buko V; Kirko S; Schneider E; Kuchenbauer F; Kumar M; Günes C; Genze F; Büchele B; Simmet T; Haslbeck M; Masur K; Barth T; Müller-Enoch D; Wirth T; Haehner T
Can J Gastroenterol Hepatol; 2021; 2021():8854432. PubMed ID: 33604316
[TBL] [Abstract][Full Text] [Related]
2. Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
Diesinger T; Buko V; Lautwein A; Dvorsky R; Belonovskaya E; Lukivskaya O; Naruta E; Kirko S; Andreev V; Buckert D; Bergler S; Renz C; Schneider E; Kuchenbauer F; Kumar M; Günes C; Büchele B; Simmet T; Müller-Enoch D; Wirth T; Haehner T
PLoS One; 2020; 15(7):e0235990. PubMed ID: 32701948
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Wu D; Cederbaum A
Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
[TBL] [Abstract][Full Text] [Related]
4. ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis.
Diesinger T; Lautwein A; Buko V; Belonovskaya E; Lukivskaya O; Naruta E; Kirko S; Andreev V; Dvorsky R; Buckert D; Bergler S; Renz C; Müller-Enoch D; Wirth T; Haehner T
Physiol Rep; 2021 Mar; 9(6):e14795. PubMed ID: 33769703
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway.
Gong P; Cederbaum AI; Nieto N
J Biol Chem; 2003 Aug; 278(32):29693-700. PubMed ID: 12777398
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CYP2E1 enhances sensitivity of hepG2 cells to fas-mediated cytotoxicity.
Yan QG; Shi JG; Zhang F; Zhao QT; Pang XW; Chen R; Hu PZ; Li QL; Wang Z; Huang GS
Cancer Biol Ther; 2008 Aug; 7(8):1280-7. PubMed ID: 18497573
[TBL] [Abstract][Full Text] [Related]
7. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2E1 increases the sensitivity of hepatoma cells to vitamin K2.
Li L; Wang L; Song R; Chen G; Liu Y
Int J Oncol; 2017 May; 50(5):1832-1838. PubMed ID: 28339022
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
Surapaneni KM; Priya VV; Mallika J
Eur Rev Med Pharmacol Sci; 2014; 18(18):2736-41. PubMed ID: 25317811
[TBL] [Abstract][Full Text] [Related]
10. Development and properties of HepG2 cells that constitutively express CYP2E1.
Wu D; Cederbaum AI
Methods Mol Biol; 2008; 447():137-50. PubMed ID: 18369917
[TBL] [Abstract][Full Text] [Related]
11. From hepatofibrosis to hepatocarcinogenesis: Higher cytochrome P450 2E1 activity is a potential risk factor.
Gao J; Wang Z; Wang GJ; Gao N; Li J; Zhang YF; Zhou J; Zhang HX; Wen Q; Jin H; Qiao HL
Mol Carcinog; 2018 Oct; 57(10):1371-1382. PubMed ID: 29917271
[TBL] [Abstract][Full Text] [Related]
12. Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress.
Marí M; Cederbaum AI
Hepatology; 2001 Mar; 33(3):652-61. PubMed ID: 11230746
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity.
Pérez MJ; Cederbaum AI
Free Radic Biol Med; 2002 Jul; 33(1):111-27. PubMed ID: 12086689
[TBL] [Abstract][Full Text] [Related]
14. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts.
Linhart K; Bartsch H; Seitz HK
Redox Biol; 2014; 3():56-62. PubMed ID: 25462066
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage.
Lee M; Bae MA
J Nutr Biochem; 2007 May; 18(5):348-54. PubMed ID: 16963249
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma.
Ho JC; Cheung ST; Leung KL; Ng IO; Fan ST
Int J Cancer; 2004 Sep; 111(4):494-500. PubMed ID: 15239125
[TBL] [Abstract][Full Text] [Related]
17. The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.
Pang YY; Li JD; Gao L; Yang X; Dang YW; Lai ZF; Liu LM; Yang J; Wu HY; He RQ; Huang ZG; Xiong DD; Yang LH; Shi L; Mo WJ; Tang D; Lu HP; Chen G
Cancer Med; 2020 Nov; 9(21):8004-8019. PubMed ID: 32931665
[TBL] [Abstract][Full Text] [Related]
18. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
19. Spin trapping agents (Tempol and POBN) protect HepG2 cells overexpressing CYP2E1 against arachidonic acid toxicity.
Pérez MJ; Cederbaum AI
Free Radic Biol Med; 2001 Apr; 30(7):734-46. PubMed ID: 11275473
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice.
Lu Y; Zhuge J; Wang X; Bai J; Cederbaum AI
Hepatology; 2008 May; 47(5):1483-94. PubMed ID: 18393316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
